Macedonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

agammaglobulinemia/главоболка

Врската е зачувана во таблата со исечоци
НаписиКлинички испитувањаПатенти
12 резултати

A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
We describe the development of enterovirus meningoencephalitis associated with increased adenosine deaminase in cerebrospinal fluid of a 12-year-old boy, a known case of hypogamaglobulinemia despite monthly replacement of IVIg.The patient was referred to our center with fever, headache and vomiting

[Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain].

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
We reported a case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain and lungs. A 21-year-old man was admitted because of one month history of low grade fever, headache, nausea, and amnesia. He developed agammaglobulinemia following Epstein-Barr virus

Pneumococcal meningitis in a young adult female with common variable immunodeficiency.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
METHODS Female, 22 FINAL DIAGNOSIS: Pneumococcal meningitis Symptoms: Fever • headache • neck stiffness • nuchal rigidity • photophobia METHODS Ceftriaxone Clinical Procedure: - Specialty: Neurology. OBJECTIVE Rare disease. BACKGROUND Common variable immunodeficiency (CVID) is a primary

Intravenous immunoglobulin in immunodeficiency states: state of the art.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Intravenous immunoglobulin (IVIg) has been used successfully for hypogammaglobulinemic states for more than 20 yr. In both primary and secondary situations when hypogammaglobulinemia is of clinical significance, IVIg should be the first line of treatment. In most cases, 400 mg/kg infused every 3 to

Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND Infectious complications represent a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). The etiology is postulated to be secondary to aberrations in cell-mediated immunity, as well as to therapy-related immunosuppression. Hypogammaglobulinemia,

Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND Although long-term intravenous immunoglobulin infusion is an effective treatment for children with antibody deficiencies, it can be complicated by systemic adverse reactions. OBJECTIVE To evaluate the adverse reactions of intravenous immunoglobulin therapy in patients with primary

Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Long-term intravenous immunoglobulin (IVIG) infusion is an effective treatment for children with humoral immunodeficiencies, already be complicated by systemic adverse effects. In order to determine the adverse effects of intravenous immunoglobulin in patients with antibody deficiency, 45

A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
This multicentre, open-label, prospective, single-arm study was designed to evaluate the efficacy, pharmacokinetics, and safety of IqYmune®, a highly purified 10% polyvalent immunoglobulin preparation for intravenous administration in patients with primary immunodeficiency. IqYmune® was administered

Intra cranial granulomatous disease in common variable immunodeficiency: Case series and review of the literature.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Common variable immunodeficiency (CVID) is typically characterized by hypogammaglobulinemia and often but not always recurrent infections. Paradoxically, 8-22% of patients with CVID develop granulomatous disease. Granulomata have been described in many organs including the lungs, skin, liver,

Herpes simplex virus type 2 meningitis as a manifestation of Good's syndrome.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Good's syndrome is a primary immunodeficiency phenocopy characterized for thymoma and immunodeficiency. The most frequent clinical presentation is recurrent or opportunistic infections, hematological alterations, and chronic diarrhea. We treated a 66-year-old man who consulted for 5 days of headache

Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Intravenous immunoglobulin (IVIG) is increasingly recommended for many diseases apart from primary immunodeficiency diseases (PID). Although effective and safe, adverse reactions may occur. We conducted a 2-year prospective observational study in 117 patients with PID who received regular IVIG

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.

Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Patients with agammaglobulinemia are particularly susceptible to chronic enteroviral infections of the central nervous system. Data on 42 patients were obtained by literature review, communications with other physicians, and personal experiences. Thirty-eight patients had congenital
Придружете се на нашата
страница на Facebook

Најкомплетната база на податоци за лековити билки поддржана од науката

  • Работи на 55 јазици
  • Лекови од билки поддржани од науката
  • Препознавање на билки по слика
  • Интерактивна GPS мапа - означете ги билките на локацијата (наскоро)
  • Прочитајте научни публикации поврзани со вашето пребарување
  • Пребарувајте лековити билки според нивните ефекти
  • Организирајте ги вашите интереси и останете во тек со истражувањето на новостите, клиничките испитувања и патентите

Напишете симптом или болест и прочитајте за билки што можат да помогнат, напишете билка и видете болести и симптоми против кои се користи.
* Сите информации се базираат на објавени научни истражувања

Google Play badgeApp Store badge